News
Fast reads for traders who want signal, not noise.
Last update: 6:30 AM PT
Research

Ticker Move of the Day: MRVL -11.88% after announcing $115B all-stock Lumentum deal

Support avatar Support · 1 min read · Nov 05, 2026, 6:30 AM PT

Marvell Technology shares tumbled 11.88% in regular trading on November 5, 2026, to $151.47, following the company's announcement on November 2 of a definitive merger agreement to acquire optical-chip maker Lumentum in an all-stock transaction valued at $115 billion in implied enterprise value. Under the fixed 4.5-share exchange ratio with no collar, Lumentum shareholders receive 4.5 Marvell shares per Lumentum share, but the deal's market value has already collapsed by more than a third as Marvell stock has declined sharply. Bank of America and TD Cowen both downgraded Marvell, citing concerns over equity dilution, the all-stock structure, regulatory risk, potential customer conflicts, and the challenge of integrating optical and silicon portfolios in a volatile AI infrastructure market. The fixed ratio means Lumentum's 24% acquisition premium has flipped to a 21% discount to its pre-deal price, signaling deep market doubt about deal completion or synergy realization. Investors face an uncertain 2028 closing timeline, merger execution risk, and the question of whether Marvell can effectively blend its high-speed electrical connectivity business with Lumentum's optical light sources to compete in AI data-center connectivity.

Research

Ticker Move of the Day: INTC -29% after weak Q4 forecast sparks chip sell-off

Support avatar Support · 1 min read · Nov 02, 2026, 6:30 AM PT

Intel shares plummeted 29.04% in regular trading on November 2, 2026, to $65.34, marking a continuation of the 28.58% crash that began on October 30 when the company guided Q4 revenue to $15–$16 billion versus Wall Street's $17 billion consensus and warned of prolonged personal-computer weakness lasting into 2027. The chipmaker reported a strong Q3 beat with 20.9% year-over-year revenue growth to $16.5 billion and adjusted EPS of $0.52 versus $0.39 expected, but the forward guidance collapse overshadowed earnings results and an impressive 78% jump in data-center revenue. A $300 million revenue hit from an explosion at Intel's Israel manufacturing facility adds to near-term headwinds. The selling pressure extends across the semiconductor sector, with AMD and Marvell also down sharply today, as investors reassess chip demand amid data-center spending questions and Intel's admission that the PC market slowdown will persist. Traders are watching whether AMD's earnings on November 3 provide any clarity on the health of demand or whether the sector faces a broader reset.

Research

Ticker Move of the Day: INTC -28.39% after weak Q4 guidance overshadows earnings beat

Support avatar Support · 1 min read · Oct 30, 2026, 7:30 AM PT

Intel shares plunged 28.39% in regular trading on October 30, 2026, after the company reported third-quarter earnings that beat expectations but issued a significantly weaker fourth-quarter revenue outlook. The chipmaker forecast Q4 adjusted earnings of $0.25 per share versus consensus of $0.43, and revenues of $15–$16 billion against Wall Street expectations near $17 billion. Weak personal computer demand and a manufacturing disruption in Israel citing a facility explosion contributed to the cautious guidance, despite Intel's data center and AI segment revenue surging nearly 80% annually to $7.3 billion, its strongest growth in 15 years. Management also confirmed that capital expenditures would rise sharply in 2027, with no positive free cash flow expected next year, heightening investor concern about near-term profitability and cash burn. Analysts noted the selloff marks one of Intel's worst single-session declines on record, erasing approximately $400 billion in market capitalization as investors shifted focus from AI tailwinds to execution risks and the PC market collapse.

Research

Ticker Move of the Day: ADT +34.08% after Thrive Holdings acquisition deal announced

Support avatar Support · 1 min read · Oct 29, 2026, 7:30 AM PT

ADT Inc. surged 34.08% in regular trading on October 29, 2026, following the announcement of a definitive agreement for Thrive Holdings to acquire the company in an all-cash transaction valued at approximately $7.6 billion in equity. Shareholders will receive $10.00 per share, representing a 45.6% premium over ADT's unaffected closing price of $6.87 on October 27. The transaction, backed by Apollo-managed funds and unanimously approved by ADT's board, is expected to close in early 2027, subject to a go-shop period through November 28, 2026. Thrive's permanent capital structure will provide ADT with long-term financial flexibility to invest in technology, products, and talent while maintaining existing data privacy policies. The stock showed exceptional volume with 39.2 million shares traded, well above the average daily volume of approximately 9.5 million.

Research

Ticker Move of the Day: GMAB +21% on game-changing cancer trial Phase 3 win

Support avatar Support · 1 min read · Oct 28, 2026, 7:30 AM PT

Genmab (NASDAQ:GMAB) surged 21% in regular trading on October 28 after announcing positive Phase 3 results for petosemtamab combined with Merck's Keytruda (pembrolizumab) in head and neck cancer. The LiGeR-HN1 trial met both primary endpoints at its first interim analysis, cutting the risk of death by 50% compared to pembrolizumab alone, with an overall survival hazard ratio of 0.50. The combination also showed a statistically significant improvement in objective response rate. JPMorgan upgraded Genmab to Overweight just yesterday, and TD Cowen raised its price target to $52, providing tailwind heading into today's announcement. The safety profile was reported as clean with no new safety signals identified, removing a key risk to investor enthusiasm. Genmab now looks to engage with regulatory authorities globally, and the strong data positions petosemtamab for potential near-term regulatory submissions in multiple oncology settings.

Research

Ticker Move of the Day: T -5.27% as SpaceX pushes to launch 4th wireless carrier

Support avatar Support · 1 min read · Oct 23, 2026, 7:30 AM PT

AT&T shares slid 5.27% in regular trading on October 23 as Bloomberg reported that SpaceX is in talks for access to approximately 80,000 U.S. cell tower sites to build a fourth nationwide wireless carrier. The talks with major tower companies including Crown Castle represent SpaceX's latest move to complement its earlier October acquisition of 800 MHz spectrum from Grain Management. This fresh competitive threat compounds pressure on AT&T and peers T-Mobile and Verizon, all down sharply in both early and regular trading. While no tower leases are yet signed and the spectrum deal closes only in the first half of 2027, the convergence of SpaceX's satellite infrastructure, spectral assets, and tower access negotiations suggests a material competitive test ahead for legacy carriers. Investors are now focused on whether SpaceX can convert tower discussions into binding contracts and how quickly Starlink Mobile can operationalize as a terrestrial competitor.

Research

Ticker Move of the Day: BHVN +30% after FDA accepts Vyglxia NDA resubmission

Support avatar Support · 1 min read · Oct 22, 2026, 7:30 AM PT

Biohaven Pharmaceuticals (BHVN) surged 30.3% in regular trading on October 22 after the FDA accepted its resubmission of the new drug application for Vyglxia (troriluzole), a treatment for spinocerebellar ataxia. The regulatory milestone signals the agency will complete its review under a standard timeline, potentially moving Vyglxia closer to commercial availability. Separately, Biohaven announced a $100 million non-dilutive licensing deal with Ono Pharmaceutical for its MoDE IgG degrader portfolio in Asian territories, retaining US and European rights for future monetization. The dual catalysts—regulatory progress on a mid-stage asset plus significant cash partnering revenue—address two key concerns for a clinical-stage biotech: development velocity and cash runway. Traders are now watching for the FDA's target action date and Phase 3 progress on BHV-1300 for Graves' disease.

Research

Ticker Move of the Day: SMCI +11.52% on blowout Q1 revenue guidance beat

Support avatar Support · 1 min read · Oct 21, 2026, 7:31 AM PT

Super Micro Computer (SMCI) surged 11.52% in regular trading on October 21 following the company's late Tuesday announcement of preliminary first-quarter fiscal 2027 revenue of $18.5–$19.5 billion, crushing both prior guidance of $14.5–$15.5 billion and analyst consensus near $15 billion. The server maker also raised gross margin guidance to 12.0–12.5% from 10.4–10.8%, signaling improved profitability. The upside revision was driven by explosive demand for artificial intelligence server platforms, with implied year-over-year revenue growth of approximately 280%. Supermicro's guidance lift is expected to boost the entire AI infrastructure sector, including peers like Dell and HPE, and eases investor concerns about AI spending sustainability. The company will report official earnings on November 3, 2026 at 5 p.m. EST.

Research

Ticker Move of the Day: BRZE +51% after Salesforce agrees to acquire for $5.66B

Support avatar Support · 1 min read · Oct 20, 2026, 7:30 AM PT

Braze (BRZE) surged 51% in regular trading on October 20 following Salesforce's announcement of a definitive agreement to acquire the customer engagement platform for approximately $5.66 billion in enterprise value. Salesforce will pay $47.50 per share in cash, representing a 58% premium to Braze's prior close of $30.04 on October 18. The acquisition strengthens Salesforce's Marketing Cloud and AI-powered customer engagement capabilities by integrating Braze's real-time messaging and personalization technology across mobile apps, web, email, SMS, and other channels. The transaction is expected to close in Salesforce's fiscal year 2028, subject to regulatory and shareholder approval, with Salesforce maintaining its fiscal 2027 guidance and funding the deal entirely from cash. Braze is now backed by customer giants including Canva, Instacart, Urban Outfitters, and Venmo, with recent reported revenue growth of 26.2% year-over-year to $227.2 million in the latest quarter.

Research

Ticker Move of the Day: FMC -34% after catastrophic Q3 guidance cut

Support avatar Support · 1 min read · Oct 15, 2026, 7:30 AM PT

FMC Corporation stock plummeted 34% in regular trading on October 15 following a devastating pre-market guidance revision that shocked the market. The agricultural sciences company slashed its third-quarter revenue guidance to $65–$125 million from a prior $840–$900 million, and swung EBITDA guidance to a loss of $510–$565 million from a $120–$140 million profit. Management attributed the collapse to weaker-than-expected demand and bloated channel inventory, forcing aggressive commercial actions including targeted price cuts and a restructuring of U.S. pricing and sales operations. The combination of a 52-week low stock price, $625–$675 million in one-time impacts, and years of crop-protection pricing headwinds has triggered rapid analyst target cuts from major banks. Full third-quarter results and 2027 guidance will follow on October 29, leaving investors to assess whether management's structural turnaround can stabilize the deeply distressed balance sheet.

Research

Ticker Move of the Day: BSP +33% after Berkshire Hathaway $330M private placement

Support avatar Support · 1 min read · Oct 14, 2026, 7:30 AM PT

Bending Spoons (BSP) surged 33% in regular trading on October 14 following Berkshire Hathaway's announcement of a $330 million private placement, increasing the investment giant's stake to 4%. The Italian software conglomerate is now backed by $930 million of Berkshire capital since its July 2026 IPO. Berkshire purchased 10 million shares at $33 per share, signaling continued confidence in BSP's AI-driven acquisition and operational-improvement strategy. The company has rapidly grown revenue through strategic acquisitions including Miro, Airtable, and others, posting 126% revenue growth in Q2 2026. Traders should monitor BSP's ability to sustain valuation multiples—currently trading at a trailing P/E of 180—as integration execution and organic growth metrics will determine whether Berkshire's large bet justifies its premium pricing.

Research

Ticker Move of the Day: NKE -5.2% after earnings miss and weak 2027 guidance

Support avatar Support · 1 min read · Oct 02, 2026, 7:30 AM PT

Nike (NKE) fell 5.2% during Friday's regular session to $33.27, extending losses from Thursday's post-earnings sell-off, after the athletic apparel company reported fiscal first-quarter revenue of $11.21 billion that missed analyst expectations and guided for high-single-digit revenue declines in fiscal 2027. The company's adjusted earnings per share of $0.48 beat expectations, but the bleak outlook and plans to cut staff in 2027 overshadowed the earnings beat, as Greater China revenue collapsed 26% and Nike Sportswear declined in the low double digits. CEO Elliott Hill acknowledged the company needs significant time to reset its troubled sportswear, Jordan, and China businesses under the new "Pace" restructuring plan, which targets $2.5 billion in cost savings by 2031. Analysts have slashed price targets this week, with Telsey Advisory downgrading to Market Perform at $35 and UBS warning investors against "catching a falling knife" as the stock now trades near its lowest level since 2014. Nike's year-to-date decline of nearly 45% and exclusion from the S&P 100 underscore the severity of the turnaround challenge ahead.

Research

Ticker Move of the Day: INTC +8.48% on analyst upgrades and October CPU price hikes

Support avatar Support · 1 min read · Sep 17, 2026, 7:31 AM PT

Intel (INTC) surged 8.48% to $109.58 in regular-session trading on September 17, propelled by multiple bullish catalysts unveiled today. Tigress Financial raised its price target to $145 from $118 with a Buy rating, while Northland upgraded the stock to Outperform with a $120 target, citing clear progress in Intel's turnaround and strength in the Terafab foundry partnership. Management disclosed plans for a roughly 10% PC CPU price hike in early October, signaling regained pricing power in the channel and potential margin expansion. Analysts also highlighted High-NA EUV now in high-volume manufacturing with over one million wafers processed, de-risking Intel's foundry strategy and foundational process-node comeback. The moves suggest institutional confidence that Intel's AI-driven server rebound, along with stronger product competitiveness, can drive earnings growth despite the company still operating at a net loss and carrying significant leverage. Investors will focus next on October 26 earnings and whether the promised CPU price hike materializes alongside improving foundry demand.

Research

Ticker Move of the Day: CL +2.2% on Iran tensions and Canadian tariffs escalate; Energy sector surges

Support avatar Support · 1 min read · Sep 08, 2026, 7:31 AM PT

Crude oil futures (CL=F) jumped 2.16% to above $82 during Tuesday's regular session as geopolitical tensions in the Middle East intensified following Iran's warnings over its upgraded ballistic missile capabilities and threats of imminent action against U.S. targets. Simultaneously, Canada imposed retaliatory tariffs on U.S. goods effective just after midnight, escalating the trade dispute and adding inflation concerns that support higher energy prices. The broader stock market declined on the combination of rising oil, Middle East uncertainty, and higher Treasury yields in anticipation of a potential Federal Reserve rate hike in September. Energy sector stocks benefited from the oil rally, while technology shares showed resilience despite overall market weakness. The week ahead brings crucial inflation data and Oracle earnings that could influence market direction further.

Research

Market closed for Labor Day; US equity trading resumes Tuesday, September 8

Support avatar Support · 1 min read · Sep 07, 2026, 7:31 AM PT

U.S. stock markets are closed on Monday, September 7, 2026, in observance of Labor Day, leaving traders without a regular cash equity session and preventing assignment of a primary ticker move for today. Global markets reflected premarket sentiment and overnight developments: Japan's Nikkei 225 rose 2.12%, South Korea's Kospi climbed 4.61%, and Asian tech names benefited from geopolitical repricing. Middle East tensions, including U.S. strikes on Iranian oil tankers over the weekend, drove energy prices higher and lifted volatility expectations ahead of Tuesday's reopening. European markets opened mixed, with Germany's DAX down 0.38% and the U.K. FTSE 100 marginally higher. Oil prices rose sharply as the conflict between the U.S. and Iran intensified. Traders should monitor geopolitical developments, energy sector momentum, and a hotter-than-expected August jobs report—which surprised analysts with 162,000 jobs added—when U.S. markets resume regular trading on Tuesday.

Research

Ticker Move of the Day: HOOD +2.2% on Morgan Stanley upgrade; broader tech retreat

Support avatar Support · 1 min read · Sep 01, 2026, 7:30 AM PT

Robinhood Markets (HOOD) surged in regular trading on Tuesday, September 1, buoyed by a Morgan Stanley upgrade to overweight from equal-weight rating as the investment bank praised the online brokerage's expanding platform and improving customer economics. While the broader market struggled on its first day of September—hit by rising Treasury yields to 20-month highs amid global inflation concerns and renewed U.S.-Iran tensions in the Strait of Hormuz—Robinhood's fintech positioning insulated it from the worst damage seen in semiconductor and high-growth tech names. The QQQ fell 1.2% and the Nasdaq Composite dropped 1.1% as a global bond selloff pressured long-duration growth stocks, but HOOD's upgrade highlights analyst conviction in the company's retail trading platform and user engagement improvements. Investors should monitor whether Morgan Stanley's positive view attracts other analyst upgrades in the coming weeks and how Robinhood's trading volumes respond if market volatility persists. The stock's relative strength today underscores divergent performance between fintech and chip sectors as macro headwinds resurface.

Research

Ticker Move of the Day: PYPL -12.7% on Stripe/Advent walkaway from $53B bid

Support avatar Support · 1 min read · Aug 31, 2026, 7:31 AM PT

PayPal Holdings (PYPL) plunged 12.7% in regular-session trading today as Bloomberg News reported that payment processor Stripe and private equity firm Advent International have abandoned their planned $53 billion acquisition of the fintech giant. Stripe and Advent had previously offered $60.50 per share; talks broke down after the bidders and PayPal's board failed to agree on a higher valuation. The collapse leaves PayPal to pursue an independent turnaround under new CEO Enrique Lores amid intensifying competition from digital payment platforms and slower organic growth. The drop erases months of deal-related gains and forces investors to reassess PayPal's standalone operational progress and profitability outlook. Two investment banks have slashed price targets in response, with Mizuho cutting its target to $51 and Loop Capital to $50, both citing competitive pressures and execution risk. Investors should monitor whether PayPal management explores alternative strategic options or accelerates its cost restructuring to restore investor confidence.

Research

Ticker Move of the Day: ESTC +21% on Q3 surprise upgrade

Support avatar Support · 1 min read · Aug 28, 2026, 7:31 AM PT

Elastic (ESTC) surged 21% in regular trading on Thursday, August 28, 2026, as the search and analytics company delivered third-quarter earnings that exceeded expectations and guided higher on strength in cloud adoption and AI-powered search features. The sharp move reflects renewed confidence in Elastic's enterprise market positioning and the broad technology sector rally triggered by Nvidia's blockbuster earnings and forward guidance released the prior day. Elastic shares have built momentum as investors rotated into software and infrastructure plays with visible AI monetization paths.

Research

Ticker Move of the Day: NVDA +7.6% on bullish sales outlook; Hugging Face acquisition eases AI concerns

Support avatar Support · 1 min read · Aug 27, 2026, 7:30 AM PT

Nvidia (NVDA) surged 7.6% during Thursday's regular trading session following its release of better-than-expected second-quarter earnings and a reassuring forward guidance that signaled strong AI demand and sales growth expected through fiscal 2028. CFO Colette Kress emphasized sustained momentum in AI infrastructure, easing persistent concerns that the artificial intelligence spending boom might be losing steam. The move was further amplified by reports of Nvidia's agreement to acquire Hugging Face, a major open-source AI model repository, for approximately $12.9 billion, reinforcing its dominant position in the AI ecosystem. The semiconductor giant's stock price rise lifted peers across the chip sector and buoyed the broader Nasdaq Composite, which climbed about 1% as investors rotated into growth and AI-exposed names. Nvidia's guidance signals confidence that the current AI cycle remains robust through next year, providing a crucial confidence boost to a market that has grown wary of overly optimistic tech forecasts. Watch for any commentary on supply chain constraints or competitive pressure from AMD and Intel, both down modestly today amid NVDA's dominance.

Research

Ticker Move of the Day: META +2.3% on historic $16.7B settlement

Support avatar Support · 1 min read · Aug 26, 2026, 8:34 AM PT

Meta Platforms (META) surged 2.3% during Wednesday's regular session following the company's agreement to settle a landmark social media addiction lawsuit for approximately $16.7 billion, one of the largest settlements by a tech company in recent years. The settlement resolves claims from 42 U.S. states and territories alleging that Meta's platforms deliberately exploited children and teenagers with addictive design features, resolving a major litigation overhang that had weighed on investor sentiment. While the massive financial cost represents a material expense, the resolution removes years of legal uncertainty and potential reputational damage associated with ongoing litigation. The settlement demonstrates both the high cost of defending against state-level regulatory action and Meta's pragmatic shift toward closing out its most contentious legal disputes. Investors are monitoring whether this precedent signals broader regulatory pressure on social media platforms and whether other tech giants face similar settlement exposure. Meta's platform resilience and advertising momentum remain key metrics for the remainder of the earnings season.

Research

Ticker Move of the Day: Dick's Sporting Goods (DKS) -17% on earnings miss and guides lower

Support avatar Support · 1 min read · Aug 25, 2026, 7:31 AM PT

Dick's Sporting Goods (DKS) tumbled 17% in regular trading on August 25, 2026, after the sports apparel and equipment retailer reported second-quarter earnings that fell short of Wall Street expectations and slashed its full-year profit outlook. The significant gap between expected and actual results has shaken investor confidence in the company's near-term growth prospects amid persistent softness in consumer discretionary spending. Dick's attributed the weakness to challenging retail conditions and cautious consumer behavior in athletic apparel and equipment categories. The downward guidance revision signals management's concern about maintaining margin pressure and demand headwinds through the remainder of the year. Retailers continue to face headwinds from higher input costs and shifting shopping patterns, making earnings surprises in this sector particularly impactful on equity valuations.

Research

Ticker Move of the Day: TSLA +5.14% on Shanghai delivery surge and AI robotaxi revival

Support avatar Support · 1 min read · Aug 24, 2026, 7:30 AM PT

Tesla (TSLA) surged 5.14% in regular trading today, outpacing the broad S&P 500's +0.43% gain as investors rotated into growth mega-cap exposure after a bruising week for semiconductors and tech. The move appears anchored in renewed optimism around Tesla's Shanghai manufacturing momentum and near-term robotaxi deployment announcements expected within weeks, pivoting away from macro uncertainty around Iran sanctions and U.S.-Canada tariff disputes that rattled markets early in the session. TSLA remains the clear beneficiary of a risk-on rotation within Magnificent Seven as institutional money re-enters names with tangible AI and hardware catalysts relative to pure software plays. The stock's outperformance also reflects positioning ahead of Nvidia's earnings on Wednesday—a potential breadth test for AI sector conviction. Watch for any Tesla delivery data releases and Elon Musk commentary on autonomous vehicle timelines, which continue to drive trader appetite.

Research

Ticker Move of the Day: HOWL +132.6% on definitive merger with Ambros Therapeutics

Support avatar Support · 1 min read · Aug 21, 2026, 7:30 AM PT

Werewolf Therapeutics (HOWL) surged +132.6% in premarket trading Friday, August 21, 2026, after announcing a definitive merger agreement with Ambros Therapeutics and a $150 million private placement. The biotech deal represents a transformative combination in the immunotherapy space, driving massive risk-on appetite in early trading on 91.1 million shares. The 151x volume ratio reflects institutional and retail enthusiasm for what appears to be a high-conviction biotech transaction. HOWL remains a smaller-cap name but showed genuine liquidity in the premarket session, making it a valid speculative play on biopharma M&A momentum. Traders should monitor the deal's closing timeline, regulatory approval requirements, and any counter-bids or financing contingencies that could affect the final valuation. The broader biotech sector is rallying alongside crypto and cyclicals as bond yields stabilize and risk sentiment improves after Thursday's sell-off.

Research

Ticker Move of the Day: COIN +11.8% as crypto surges on Treasury relief

Support avatar Support · 1 min read · Aug 20, 2026, 7:31 AM PT

Cryptocurrency exchange operator Coinbase (COIN) surged 11.8% in early trading on August 20, 2026, riding a broader crypto market rally sparked by the US Treasury Department's surprise announcement to double its debt buybacks. Bitcoin soared over 10%, breaking above $71,000 for the first time since June, as Treasury Secretary Scott Bessent's intervention eased concerns about long-dated bond yields hitting near 20-year highs. Lower yields and the prospect of a more dovish backdrop have historically boosted risk-on assets including cryptocurrencies and related platforms. The broader market tumbled as Treasury yields rebounded during the session—the Dow fell 0.79%, the S&P 500 dropped 0.43%, and the Nasdaq declined 0.79%—underscoring a rotation away from growth equities into fixed income. Traders should monitor whether the Treasury's buyback program sustains this crypto momentum or whether a fresh reversal in yields derails the move. Bitcoin's behavior remains key: if crypto maintains strength and draws institutional inflows, it could indicate more durable support for COIN and other digital-asset names.

Research

Ticker Move of the Day: MRNA +144% on newly filed RSV vaccine approval catalyst

Support avatar Support · 1 min read · Aug 19, 2026, 7:30 AM PT

Moderna (MRNA) surged 144% in premarket trading on August 19, 2026, following what appears to be a significant clinical or regulatory advancement in the company's RSV (respiratory syncytial virus) vaccine program. The massive move marks one of the largest single-day gains in the biotech sector in recent memory, reflecting investor enthusiasm for a potentially transformative new therapeutic. The rally underscores the outsized impact vaccine approval news or positive trial data can have on Moderna's stock, particularly in segments like RSV where unmet medical need is high. Moderna's prior vaccine platforms, including mRNA technology for COVID-19, have demonstrated both commercial viability and durability, positioning any new approval as meaningful revenue upside. The stock's move occurred as broader markets showed mixed sentiment, with the S&P 500 and Dow modestly positive but the Nasdaq under pressure from semiconductor weakness and rising bond yields. Traders should monitor Moderna's official press release and the FDA's official stance to confirm the nature and timeline of the RSV vaccine catalyst.

Research

Ticker Move of the Day: SNDK +8.9% as semiconductor demand resilience deepens

Support avatar Support · 1 min read · Aug 18, 2026, 7:32 AM PT

SanDisk (SNDK) surged 8.9% in premarket trading on August 18, 2026, extending Monday's gains as semiconductor and memory-storage stocks rally on sustained demand for AI infrastructure investment. The stock is building on the prior day's 7.4% jump, which was driven by renewed confidence in AI capex cycles signaled by recent tech-sector earnings beats. The broader S&P 500, Nasdaq, and Dow are each down 0.5–1.3% in premarket trading today as geopolitical tensions over U.S.–Iran negotiations and climbing oil prices (Brent crude above $91/barrel) drain investor appetite for growth equities and push long-dated Treasury yields to multi-decade highs. Memory and storage makers are bucking the selloff, as institutional investors view them as direct beneficiaries of hyperscale datacenter spending that remains robust despite macro headwinds. SNDK's sustained rally underscores the divergence between "AI winners" and the broader market downturn; investors should monitor whether semiconductor leadership can narrow the gap or widen it further given today's negative macro backdrop.

Research

Ticker Move of the Day: SNDK +7.4% on AI demand and semiconductor momentum

Support avatar Support · 1 min read · Aug 17, 2026, 7:31 AM PT

SanDisk (SNDK) surged 7.4% in premarket trading on Monday, August 17, 2026, as investors rotated into semiconductor and memory-storage plays on the back of strong AI demand signals. The rally is anchored in renewed confidence about AI infrastructure spending, sparked by Anthropic's stellar revenue growth reported over the weekend—signaling that massive capital expenditures on datacenters and AI chips remain robust despite macroeconomic headwinds. Storage and memory makers, long positioned as critical enablers of AI scaling, stand to benefit from sustained enterprise and hyperscaler investment cycles. SanDisk shares have already gained approximately sixfold this year and remain bid by JPMorgan analysts, who upgraded the stock and set a $2,250 price target implying 47% upside from Thursday's close. Traders should monitor semiconductor sector rotation, earnings from chipmakers like Micron and Western Digital this week, and whether AI spending sustainability narratives hold as retail earnings season begins.

Research

Ticker Move of the Day: RDDT +12.4% on S&P 500 index inclusion

Support avatar Support · 1 min read · Aug 14, 2026, 7:30 AM PT

Reddit (RDDT) surged 12.4% in premarket trading on August 14 after S&P Dow Jones Indices announced that the online social network will join the S&P 500 index before the opening bell on August 18, 2026. The index-inclusion catalyst is a significant institutional event that typically drives price appreciation as passive and algorithmic funds automatically add the stock to their holdings. Reddit's move comes as the social media platform has demonstrated sustained user engagement and profitability improvements, making it an attractive addition to the benchmark. The stock's inclusion will elevate its profile among institutional investors and broaden its ownership base. Traders should watch for execution risk during the index rebalancing on Sunday evening and opening-bell liquidity on Monday. Retail traders monitoring sentiment around AI-adjacent platforms and community-driven content networks may find Reddit's newfound index status a key pivot point for medium-term positioning.

Research

EnerSys Surges 13% On Strong Earnings And Revenue Beat

Support avatar Support · 1 min read · Aug 13, 2026, 7:31 AM PT

EnerSys (ESL), a leading manufacturer of energy storage and management solutions, jumped 13% in early trading on August 13 after reporting fiscal first-quarter earnings and revenue that significantly exceeded Wall Street expectations. The company posted adjusted earnings of $3.66 per share against a FactSet consensus of $2.84, while revenue came in at $935.6 million versus the expected $928 million, driven by strong demand for battery and power solutions in industrial and infrastructure segments. The substantial beat, coupled with improving margins and operational efficiency, signaled robust execution in a market increasingly focused on energy transition and data center infrastructure buildout. EnerSys' outperformance contrasts with recent mixed earnings results and comes as the broader market rallied on moderating inflation data, with the S&P 500 approaching fresh all-time highs. Investors should monitor ESL's forward guidance, capital deployment plans, and its exposure to data center and renewable-energy investment cycles, which remain key growth drivers in the sector.

Research

Ticker Move of the Day: CAVA +16% on strong Q2 earnings beat

Support avatar Support · 1 min read · Aug 12, 2026, 7:31 AM PT

Cava Group (CAVA), the fast-casual Mediterranean restaurant chain, surged 16% in early trading Wednesday after reporting second-quarter 2026 financial results that exceeded analyst expectations. The company's strong earnings and restaurant-level economics demonstrate continued consumer demand for its growth-focused dining model, even amid broader uncertainty about discretionary spending. The stock's surge reflects investor confidence in Cava's unit-economics sustainability and market expansion potential. H&R Block (HRB) also rallied 12% on better-than-expected fourth-quarter results, signaling that earnings-driven moves are supporting the broader tape. Market sentiment tilted toward tech and AI infrastructure names following cooler-than-expected July CPI data, which provided relief on inflation but kept the Fed's rate path uncertain heading into September. Traders should monitor Cava's guidance execution and competitive dynamics in the fast-casual segment as the retail environment shows mixed signals.

Research

Ticker Move of the Day: DDOG +11.5% on strong Q2 earnings and analyst upgrades

Support avatar Support · 1 min read · Aug 11, 2026, 7:31 AM PT

Datadog (DDOG) surged 11.48% in premarket and early regular-session trading Tuesday after reporting second-quarter 2026 results that beat analyst expectations on both revenue and profitability metrics. The software monitoring platform reported strong organic growth and improved margins, driving broad confidence among institutional investors and renewed optimism around its cloud-infrastructure positioning. Multiple analysts raised price targets on the stock following the earnings release, citing strong execution and sustained demand from enterprise customers navigating AI adoption and infrastructure modernization. The rally extends Datadog's momentum from a period of solid financial performance, reflecting broader investor appetite for cloud and observability software plays. DDOG remains near its premarket highs as traders position for potential guidance remarks and the potential for further upward revisions as the quarter progresses. Investors should monitor analyst updates and forward guidance commentary for clues about cloud spending cycles in coming quarters.

Research

Ticker Move of the Day: VRTX +7.2% on beat earnings and biotech momentum

Support avatar Support · 1 min read · Aug 10, 2026, 7:31 AM PT

Vertex Pharmaceuticals surged 7.2% in premarket trading on August 10 after reporting second-quarter earnings that exceeded analyst expectations, buoying investor sentiment in the biotech sector. The company's strong earnings signal sustained efficacy and commercial traction in its core business, contrasting with the mixed backdrop of earnings reports and macro uncertainty this week. Vertex's outperformance comes as the broader market awaits key inflation data (CPI) on Wednesday and Producer Price Index (PPI) on Thursday, which will inform expectations for Federal Reserve policy. The biotech sector has shown relative resilience amid cautious risk management by institutional investors rotating from mega-cap tech names. Traders should watch for sector breadth over the next 48 hours and monitor whether CPI surprises trigger volatility across healthcare and defensive equities.